Report suggests regulatory system for medicines can be used more effectively
18.09.14
Our latest learning from genomics and our improved understanding of human biology have resulted in a record number of promising break-through medicines in development. When entering a new era of personalised medicine, the current model for medicines development and approval may not be appropriate. Against this background, EFPIA decided to provide an unrestricted research grant to the Escher platform to explore if the model is fit for purpose.
Please read the full press release here.